The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
about
Hemoglobin-based oxygen carriersChinese herbal medicines for the treatment of neonatal jaundiceSafety of the blood supply in Latin AmericaHealth Technology Assessment of pathogen reduction technologies applied to plasma for clinical useThyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspectiveThe natural history of hepatitis C virus (HCV) infection.Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virusCosts and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infectionHb-based oxygen carriers: are we there yet?Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmissionThe epidemiology of hepatitis C in a UK health regional population of 5.12 millionDiagnosis, management, and treatment of hepatitis C: an updateGuidelines for the assessment and acceptance of potential brain-dead organ donors.Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study.Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates.How I manage cerebral vasculopathy in children with sickle cell disease.Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2Effectiveness of DNA-recombinant anti-hepatitis B vaccines in blood donors: a cohort studyTransfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot study.Hepatitis C virus infection and long-term survivors of childhood cancer: issues for the pediatric oncology nurse.Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.Which is safer source plasma for manufacturing in China: apheresis plasma or recovered plasma?Evaluation of surrogate markers for human immunodeficiency virus infection among blood donors at the blood bank of "Hospital Universitário Regional Norte do Paraná", Londrina, PR, Brazil.Human immunodeficiency virus test-seeking blood donors in a large blood bank in São Paulo, Brazil.Pre-donation screening of blood for transfusion transmissible infections: the gains and the pains - experience at a resource limited blood bankBone bank service in Finland. Experience of bacteriologic, serologic and clinical results of the Turku Bone Bank 1972-1995.SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available.Rate of seroconversion in repeat blood donors at the national blood centre, kuala lumpur.Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports.Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors: a report from the Childhood Cancer Survivor Study.Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2.Tissue oxygenation after exchange transfusion with ultrahigh-molecular-weight tense- and relaxed-state polymerized bovine hemoglobins.Oversight and monitoring of blood safety in the United States.Modelers' perception of mathematical modeling in epidemiology: a web-based survey.Hepatitis C: a challenge for the generalist.Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trialHepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.Hepatitis viruses and the safety of blood donations.Genomic screening for blood-borne viruses in transfusion settings.The release of unsuitable units through misinterpretation of laboratory results transmitted by facsimile.
P2860
Q21195084-ACB5A14F-03B2-45E3-AF53-C80C65944090Q24239917-0A337CF9-6A69-4EC8-9975-6947B299A7ADQ24557539-1C78B463-9244-4521-86C7-6A64809A7F3FQ26741073-ABB30CB0-389E-4D0A-9208-8F89C99B52DBQ26827517-62872591-5078-4B15-8759-E6AC35B4A7F7Q27473116-CF9BC2EF-2EBF-4E11-9BEB-0DA35FC46FC4Q27485791-DD961DD4-80A5-4BEA-920B-3DE25183114DQ27487452-46463F69-C13E-44BB-A1D1-4A7517BE1459Q28206212-4D14727D-03D9-443F-B871-1F20EE00B296Q28207253-A2A4CAB3-DE5F-4A58-ACF0-3EC5B507ED9DQ28362636-228ED262-8DDE-4183-B5AD-E9B058697DB6Q29619682-2DD2A967-7FBA-45A1-847E-3FD5170B204DQ30372798-5A092BED-47F5-4084-8569-85735FE81A03Q30394281-2AA0B547-FAED-411C-B8EA-21AD52923CCCQ30431256-E2AF5301-38A2-45E0-81CE-9BB416A23B74Q30945117-0BFD37AD-399C-4849-9E32-37F2618FC73DQ33187703-186F496F-BD3C-4989-A744-9134460EC11FQ33305140-4F4B015F-0785-4BD6-882E-A251DB6BCC38Q33332057-EF84B292-2E04-420F-BF80-BD7CE6372DF1Q33335845-8A5D5DD3-3E17-4F9E-AF41-9887CD3A2E4EQ33371166-B4F6D833-4981-4A46-BA91-CBC59A45C049Q33432155-3A8A72CB-E84C-49D6-B0B9-79B1E2EA390FQ33445671-7FB33280-0BD7-4F7D-AE85-092B1467EFECQ33452535-0B711E1B-D360-4DE5-B70A-72513F8470BEQ33457204-E6E99AE6-4DBE-4A30-9554-F8CCF8B38B1CQ33464763-05F938A1-BAF7-49CD-A5E9-0C8F3DDB5F8CQ33504054-CDD31794-7C97-4A13-9206-E0204EB5B0EAQ33619619-B72E04DC-5DF3-4966-9E79-ADB38FCEB20DQ33623655-FC52E533-207B-4036-84F1-2701D13092EFQ33643564-DB646897-2E2B-42EF-936A-8EE7BDD427CBQ33668746-2153C38A-B811-40A9-A41F-DC40260EEA68Q33727519-C47572BD-F716-41E1-B11E-D148757D3DC8Q33749419-D624670E-9D77-44A4-9BB0-BC3F7B4E8A1DQ33815673-DC14AC78-F98D-460B-8C8E-D5591B536DB7Q33823470-F703F852-DCE1-4F4A-9273-560C45E7987CQ33832768-64E8AC45-8988-4E8D-93F2-C03FF7FCBD98Q33866448-41BA71E3-6F6C-47E7-BF87-573175CB988AQ33888797-36874822-3BE7-47A3-9A2A-6DCEDF7D7AADQ33890340-6C5ED9E3-E524-439A-BE37-0C1E29D3CB92Q33895381-58EE9157-C419-4127-A0E9-5705978DD20D
P2860
The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
The risk of transfusion-transm ...... irus Epidemiology Donor Study.
@en
The risk of transfusion-transm ...... irus Epidemiology Donor Study.
@nl
type
label
The risk of transfusion-transm ...... irus Epidemiology Donor Study.
@en
The risk of transfusion-transm ...... irus Epidemiology Donor Study.
@nl
prefLabel
The risk of transfusion-transm ...... irus Epidemiology Donor Study.
@en
The risk of transfusion-transm ...... irus Epidemiology Donor Study.
@nl
P2093
P1476
The risk of transfusion-transm ...... irus Epidemiology Donor Study.
@en
P2093
Kleinman SH
Korelitz JJ
Schreiber GB
P304
P356
10.1056/NEJM199606273342601
P407
P577
1996-06-01T00:00:00Z